Inactive Instrument

Hospira, Inc. Stock

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

04/08/15	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/07/15	Allergan : Mylan independence from Teva's embrace comes with a price	RE

Latest news: Hospira, Inc.

04/08/15	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/07/15	Allergan : Mylan independence from Teva's embrace comes with a price	RE
14/07/15	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
03/07/15	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount	RE
06/05/15	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal	RE
14/04/15	AbbVie : Banks see talent flee amid healthcare M&A boom	RE
09/04/15	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo	RE
05/03/15	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
05/03/15	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
05/03/15	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
25/02/15	Celltrion : Biosimilar copies of blockbuster drug launch in major EU markets	RE
06/02/15	Pfizer : to buy Hospira for $15 billion to bolster hospital products	RE
06/02/15	Hospira : Pfizer's Hospira deal bets on price spike for specialty generics	RE

Press Releases: Hospira, Inc.

27/08/15	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
27/08/15	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
21/08/15	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
20/08/15	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
20/08/15	Hospira : TGA Approves First mAb Biosimilar	PR

More press releases

News in other languages: Hospira, Inc.

28/08/15	Activision Blizzard et United Continental intègrent le S&P-500
24/08/15	Apple : Les valeurs à suivre à Wall Street
24/08/15	USA-Les valeurs à suivre à Wall Street
03/08/15	American : Les valeurs à suivre sur les marchés américains
03/08/15	USA-Les valeurs à suivre à Wall Street

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	-2.54%	+1.31%	+54.27%	+114.96%	1,135B
	JOHNSON & JOHNSON	-1.42%	+3.23%	+38.56%	+74.44%	636B
	ABBVIE INC.	+0.16%	+0.08%	+25.29%	+95.23%	505B
	ROCHE HOLDING AG	-0.31%	+3.09%	+43.92%	+64.55%	378B
	MERCK & CO., INC.	-1.34%	-0.47%	+66.04%	+41.00%	358B
	NOVARTIS AG	-0.68%	+2.65%	+22.46%	+51.48%	295B
	ASTRAZENECA PLC	-1.20%	+3.04%	+2.62%	+26.97%	266B
	AMGEN INC.	-1.79%	+1.57%	+50.56%	+59.08%	237B
	GILEAD SCIENCES, INC.	-0.73%	-0.10%	+29.02%	+99.67%	193B
	Average	-1.09%	+2.17%	+36.97%	+69.71%	444.93B
	Weighted average by Cap.	-1.35%	+2.66%	+40.98%	+80.08%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!